Hindustan Unilever Ltd
Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments. The Company has manufacturing facilities across the country and sells primarily in India.[1]
- Market Cap ₹ 5,24,335 Cr.
- Current Price ₹ 2,232
- High / Low ₹ 2,770 / 2,170
- Stock P/E 51.1
- Book Value ₹ 214
- Dividend Yield 1.75 %
- ROCE 26.2 %
- ROE 20.2 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 21.5%
- Company has been maintaining a healthy dividend payout of 101%
Cons
- Stock is trading at 10.4 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Multinational
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
22,116 | 25,810 | 28,019 | 30,806 | 31,061 | 31,890 | 34,525 | 38,224 | 38,785 | 45,996 | 51,193 | 59,144 | 60,505 | |
18,809 | 21,796 | 23,532 | 25,600 | 25,312 | 25,843 | 27,249 | 29,587 | 29,185 | 34,672 | 38,690 | 45,512 | 46,279 | |
Operating Profit | 3,307 | 4,015 | 4,488 | 5,205 | 5,749 | 6,047 | 7,276 | 8,637 | 9,600 | 11,324 | 12,503 | 13,632 | 14,226 |
OPM % | 15% | 16% | 16% | 17% | 19% | 19% | 21% | 23% | 25% | 25% | 24% | 23% | 24% |
381 | 1,204 | 837 | 1,285 | 533 | 767 | 507 | 437 | 536 | 286 | 359 | 578 | 921 | |
Interest | 1 | 25 | 36 | 17 | 15 | 22 | 20 | 28 | 106 | 108 | 98 | 101 | 224 |
Depreciation | 218 | 236 | 261 | 287 | 321 | 396 | 478 | 524 | 938 | 1,012 | 1,025 | 1,030 | 1,070 |
Profit before tax | 3,469 | 4,958 | 5,028 | 6,187 | 5,946 | 6,396 | 7,285 | 8,522 | 9,092 | 10,490 | 11,739 | 13,079 | 13,853 |
Tax % | 22% | 23% | 23% | 30% | 30% | 30% | 28% | 29% | 26% | 24% | 25% | 24% | |
2,691 | 3,797 | 3,867 | 4,315 | 4,137 | 4,490 | 5,237 | 6,036 | 6,738 | 7,954 | 8,818 | 9,962 | 10,260 | |
EPS in Rs | 12.45 | 17.56 | 17.88 | 19.95 | 19.12 | 20.75 | 24.19 | 27.88 | 31.12 | 33.85 | 37.53 | 42.40 | 43.66 |
Dividend Payout % | 60% | 105% | 73% | 75% | 84% | 82% | 82% | 79% | 80% | 120% | 91% | 92% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 11% |
3 Years: | 15% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | 12% |
5 Years: | 14% |
3 Years: | 13% |
TTM: | 5% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 5% |
3 Years: | -2% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | 37% |
5 Years: | 29% |
3 Years: | 22% |
Last Year: | 20% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 235 | 235 | 235 | 235 |
Reserves | 3,297 | 2,458 | 3,061 | 3,508 | 6,063 | 6,274 | 6,859 | 7,443 | 7,815 | 47,199 | 48,525 | 49,986 | 50,025 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 943 | 971 | 1,039 | 1,094 | |
7,445 | 8,838 | 9,721 | 9,909 | 7,641 | 8,261 | 10,074 | 10,206 | 11,571 | 19,739 | 20,006 | 20,565 | 25,097 | |
Total Liabilities | 10,958 | 11,512 | 12,998 | 13,634 | 13,920 | 14,751 | 17,149 | 17,865 | 19,602 | 68,116 | 69,737 | 71,825 | 76,451 |
2,147 | 2,293 | 2,422 | 2,458 | 2,914 | 4,024 | 4,142 | 4,343 | 5,056 | 51,027 | 51,034 | 51,405 | 51,767 | |
CWIP | 215 | 216 | 320 | 479 | 386 | 203 | 430 | 373 | 513 | 623 | 901 | 1,020 | 900 |
Investments | 2,438 | 2,331 | 3,094 | 3,278 | 2,780 | 3,779 | 3,111 | 2,949 | 1,500 | 2,995 | 4,122 | 3,794 | 5,564 |
6,157 | 6,673 | 7,162 | 7,420 | 7,840 | 6,745 | 9,466 | 10,200 | 12,533 | 13,471 | 13,680 | 15,606 | 18,220 | |
Total Assets | 10,958 | 11,512 | 12,998 | 13,634 | 13,920 | 14,751 | 17,149 | 17,865 | 19,602 | 68,116 | 69,737 | 71,825 | 76,451 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2,872 | 3,530 | 3,724 | 3,272 | 3,974 | 4,953 | 5,913 | 5,728 | 7,305 | 8,957 | 8,964 | 9,626 | |
-452 | 34 | -513 | 280 | -51 | -752 | -1,261 | -264 | 1,926 | -1,067 | -1,732 | -1,062 | |
-1,725 | -4,160 | -2,917 | -3,450 | -4,008 | -4,264 | -4,651 | -5,462 | -6,676 | -9,280 | -7,984 | -8,966 | |
Net Cash Flow | 695 | -597 | 294 | 101 | -85 | -63 | 1 | 2 | 2,555 | -1,390 | -752 | -402 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 11 | 12 | 11 | 9 | 12 | 11 | 12 | 16 | 10 | 13 | 14 | 17 |
Inventory Days | 93 | 80 | 83 | 72 | 71 | 65 | 62 | 57 | 63 | 64 | 63 | 53 |
Days Payable | 172 | 164 | 170 | 146 | 155 | 165 | 186 | 167 | 177 | 162 | 145 | 122 |
Cash Conversion Cycle | -67 | -72 | -76 | -65 | -71 | -89 | -111 | -94 | -104 | -86 | -67 | -53 |
Working Capital Days | -45 | -51 | -57 | -55 | -27 | -35 | -39 | -32 | -33 | -31 | -22 | -16 |
ROCE % | 105% | 135% | 154% | 150% | 120% | 97% | 109% | 119% | 120% | 38% | 24% | 26% |
Documents
Announcements
- Intimation Of Earnings Conference Call For The Quarter And Year Ended 31St March, 2024 1d
- Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended 31St March, 2024. 16 Apr
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 16 Apr
- Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Apr
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 15 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
Concalls
-
Jan 2024Transcript PPT
-
Oct 2023Transcript PPT
-
Jul 2023Transcript PPT
-
May 2023Transcript PPT REC
-
Jan 2023TranscriptNotesPPT
-
Dec 2022TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Oct 2022TranscriptNotesPPT
-
Jul 2022TranscriptNotesPPT
-
Apr 2022TranscriptNotesPPT
-
Apr 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Oct 2021TranscriptNotesPPT
-
Sep 2021TranscriptNotesPPT
-
Sep 2021TranscriptNotesPPT
-
Jul 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
-
Apr 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Jan 2021TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
-
Oct 2020TranscriptNotesPPT
-
Sep 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Apr 2020TranscriptNotesPPT
-
Apr 2020TranscriptNotesPPT
-
Jan 2020TranscriptNotesPPT
-
Dec 2019TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Oct 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Jul 2019TranscriptNotesPPT
-
Jun 2019TranscriptNotesPPT
-
Jun 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Jan 2019TranscriptNotesPPT
-
Dec 2018TranscriptNotesPPT
-
Dec 2018TranscriptNotesPPT
-
Dec 2018TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Oct 2018TranscriptNotesPPT
-
Sep 2018TranscriptNotesPPT
-
Sep 2018TranscriptNotesPPT
-
Jun 2018TranscriptNotesPPT
-
May 2018Transcript PPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Jan 2018TranscriptNotesPPT
-
Oct 2017TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
Jun 2017TranscriptNotesPPT
-
Jun 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Oct 2016TranscriptNotesPPT
-
Jul 2016Transcript PPT
-
Jan 2016TranscriptNotesPPT
Beauty & Personal Care Segment (42% of revenues)[1]
In this segment, the company has a wide-spread portfolio of more than 900 SKUs spread across one or more of categories which are made for 14 consumer clusters identified in India.[2] The company earns ~29% margins from this segment which is the most among its divisions.[1]
Brands under segment :-
Skin Cleansing - Dove, Lifebuoy, LUX, Pears, Liril, Hamam, Lever Ayush
Oral Care - Pepsodent, Closeup, Lever Ayush
Hair Care - Tresemme, Dove, Indulekha, Lever Ayush
Skin Care - Glow & Lovely, Pond's, Vaseline, Lakme, Lever Ayush.
Color Cosmetics - Lakme[3][4]